Conditions: Lung Cancer (Diagnosis); Osteochondroma; Spitz Nevus; Solid Cancers; Breast Cancer; Gastric (Stomach) Cancer; Colorectal (Colon or Rectal) Cancer; Sarcoma; Ovarian Adenocarcinoma; Uterine Adenocarcinoma; Endometrial Adenocarcinoma; Esophageal Adenocarcinoma; Head and Neck Cancer; Therapy-Related Acute Myeloid Leukemia; Therapy-Related MDS; Clonal Hematopoiesis of Indeterminate Potential (CHIP); Clonal Cytopenia of Undetermined Significance
Interventions: Other: Samples
Sponsors: Dana-Farber Cancer Institute
**RECRUITING NOW**
Interventions: Other: Samples
Sponsors: Dana-Farber Cancer Institute
**RECRUITING NOW**
Source: View full study details on ClinicalTrials.gov
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
